Skip to main content
. 2018 Dec 20;62(2):641–653. doi: 10.1021/acs.jmedchem.8b01327

Table 1. Binding Affinities at the Opioid Receptors and Calculated Physicochemical Properties of 6-Amino Acid (221)- and 6-Dipeptide-Substituted Derivatives (22a/b and 23a), and Reference Compound 1.

    opioid receptor binding Ki (nM)a
physicochemical propertiesb
compd amino acid substitution at position 6 MOR DOR KOR Ki ratio MOR/DOR/KOR c log D7.4
1c   0.10 ± 0.01 4.80 ± 0.22 10.2 ± 2.0 1/48/102 0.48
2ac α-Gly 0.89 ± 0.09 15.4 ± 1.4 43.2 ± 7.0 1/7/49 –3.35
2bc β-Gly 0.83 ± 0.02 7.86 ± 0.64 44.8 ± 0.1 1/9.5/54 –3.35
3ac α-l-Ala 0.77 ± 0.09 26.9 ± 0.8 142 ± 43 1/35/184 –2.81
3bc β-l-Ala 1.90 ± 0.08 7.71 ± 0.94 63.7 ± 7.8 1/4.1/34 –2.81
4ac α-l-Phe 0.95 ± 0.07 3.67 ± 0.32 28.5 ± 4.2 1/3.9/30 –1.13
4bc β-l-Phe 2.58 ± 0.09 1.03 ± 0.13 151 ± 17 1/0.4/59 –1.13
5ad α-Gly 0.19 ± 0.02 0.22 ± 0.02 0.73 ± 0.01 1/1.2/3.8 –0.85
5bd β-Gly 0.16 ± 0.02 0.19 ± 0.01 0.81 ± 0.03 1/1.2/5.1 –0.85
6a α-l-Ser 2.21 ± 0.02 5.32 ± 0.39 196 ± 24 1/2.4/89 –3.89
6b β-l-Ser 2.14 ± 0.03 5.29 ± 0.31 152 ± 15 1/2.5/71 –3.89
7a α-l-Val 3.16 ± 0.25 3.91 ± 0.30 325 ± 19 1/1.2/103 –1.94
7b β-l-Val 3.04 ± 0.12 3.52 ± 0.04 305 ± 39 1/1.2/100 –1.94
8a α-l-Lys 0.19 ± 0.04 1.27 ± 0.42 12.6 ± 1.3 1/6.7/66 –5.57
8b β-l-Lys 0.53 ± 0.09 3.34 ± 0.46 33.7 ± 4.1 1/6.3/64 –5.57
9a α-l-Tyr 0.83 ± 0.04 2.18 ± 0.98 39.5 ± 0.2 1/2.6/48 –1.41
9b β-l-Tyr 3.20 ± 0.55 3.89 ± 0.64 186 ± 33 1/1.2/58 –1.41
10a α-l-Trp 0.36 ± 0.01 1.02 ± 0.12 25.1 ± 9.3 1/2.8/70 –1.03
10b β-l-Trp 0.65 ± 0.09 1.19 ± 0.40 8.66 ± 0.64 1/1.8/13 –1.03
11a α-l-Asn 1.17 ± 0.07 3.37 ± 0.21 74.0 ± 9.7 1/2.9/63 –4.29
11b β-l-Asn 1.26 ± 0.05 2.25 ± 0.11 103 ± 10 1/1.8/82 –4.29
12a α-l-Gln 3.24 ± 0.14 5.13 ± 0.52 351 ± 66 1/1.6/108 –4.04
12b β-l-Gln 2.48 ± 0.30 4.87 ± 0.76 290 ± 3 1/2.0/117 –4.04
13a α-l-Asp 1.36 ± 0.05 14.6 ± 3.6 50.2 ± 9.2 1/11/37 –5.64
13b β-l-Asp 3.42 ± 0.05 22.6 ± 2.2 351 ± 43 1/6.6/103 –5.64
14a α-l-Glu 1.45 ± 0.09 9.03 ± 0.70 87.2 ± 4.2 1/6.2/60 –5.39
14b β-l-Glu 11.6 ± 0.7 7.64 ± 0.64 1252 ± 70 1/0.7/108 –5.39
15a α-d-Ala 0.69 ± 0.11 10.4 ± 0.01 71.5 ± 9.6 1/15/104 –2.81
15b β-d-Ala 1.48 ± 0.08 11.3 ± 0.9 142 ± 33 1/7.6/96 –2.81
16a α-d-Val 1.70 ± 0.09 1.93 ± 0.24 202 ± 3 1/1.1/119 –1.94
16b β-d-Val 1.02 ± 0.07 1.68 ± 0.16 159 ± 17 1/1.6/156 –1.94
17a α-d-Phe 0.61 ± 0.01 3.69 ± 0.59 76.4 ± 9.3 1/6.0/125 –1.13
17b β-d-Phe 1.28 ± 0.38 1.19 ± 0.13 139 ± 23 1/0.9/109 –1.13
18a α-l-Chg 1.23 ± 0.20 14.3 ± 0.09 177 ± 30 1/12/144 –1.26
18b β-l-Chg 1.66 ± 1.04 1.30 ± 0.16 118 ± 23 1/0.8/71 –1.26
19a α-l-Abu 0.76 ± 0.19 37.5 ± 3.4 144 ± 7 1/49/189 –2.34
19b β-l-Abu 1.83 ± 0.04 1.30 ± 0.24 201 ± 10 1/0.7/110 –2.34
20a α-β-Ala 1.30 ± 0.08 60.0 ± 1.9 182 ± 8 1/46/140 –3.18
20b β-β-Ala 1.04 ± 0.04 13.9 ± 1.7 71.4 ± 4.6 1/13/69 –3.18
21a α-GABA 0.77 ± 0.07 12.5 ± 0.7 45.6 ± 4.4 1/16/59 –2.93
21b β-GABA 1.41 ± 0.13 6.61 ± 0.67 147 ± 13 1/4.7/104 –2.93
22a α-l-Val-l-Tyr 0.82 ± 0.13 1.19 ± 0.42 69.0 ± 2.5 1/1.5/84 –1.02
22b β-l-Val-l-Tyr 0.44 ± 0.01 1.38 ± 0.22 390 ± 49 1/3.1/886 –1.02
23a β-Gly-Gly 4.62 ± 0.09 7.52 ± 0.43 203 ± 34 1/1.6/44 –4.27
a

Determined in competition radioligand binding assays using rat brain membranes (MOR and DOR) and guinea-pig brain membranes (KOR). Values represent the mean ± SEM of three to four independent experiments each performed in duplicate.

b

Calculated using the MarvinSketch 18.8 (ChemAxon).

c

Data from ref (44).

d

Data from ref (49).